1-4 of 4
Yuanyuan Shao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Yihao Wang, Hong Yu, Yuanyuan Shao, Huijuan Jiang, Shan Gao, Lijuan Li, Rong Fu, Zonghong Shao
Journal: Blood
Blood (2022) 140 (Supplement 1): 3739–3740.
https://doi.org/10.1182/blood-2022-164677
Published: 2022
Journal Articles

The Effect of Pyruvate Kinase M2: Inhibitor(shikonin) on the Function of Mdc in Severe Aplastic Anemia Mouse Model

Mengying Zheng, Chunyan Liu, Yuanyuan Shao, Rong Fu, Jr., PhD, Huaquan Wang, MD, Ting Wang, Weiwei Qi, Zonghong Shao
Journal: Blood
Blood (2019) 134 (Supplement_1): 5021.
https://doi.org/10.1182/blood-2019-126726
Published: 2019
Journal Articles

Study of IgG Subclass of the Patients with Immuno-Related Hemocytopenia

Zonghong Shao, MD, Yuanyuan Shao, Rong Fu, PhD
Journal: Blood
Blood (2015) 126 (23): 4604.
https://doi.org/10.1182/blood.V126.23.4604.4604
Published: 2015
Journal Articles

IgG Subclasses Abnormal in Immune-Related Pancytopenia

Zonghong Shao, MD, Yuanyuan Shao, Rong Fu, PhD
Journal: Blood
Blood (2014) 124 (21): 5158.
https://doi.org/10.1182/blood.V124.21.5158.5158
Published: 2014